Literature DB >> 15505267

Use of implantable cardioverter defibrillators after out-of-hospital cardiac arrest: a prospective follow-up study.

Ratika Parkash1, Anthony Tang, George Wells, Josée Blackburn, Ian Stiell, Christopher Simpson, Paul Dorian, Raymond Yee, Doug Cameron, Stuart Connolly, David Birnie, Graham Nichol.   

Abstract

BACKGROUND: Survivors of out-of-hospital cardiac arrest are at high risk of recurrent arrests, many of which could be prevented with implantable cardioverter defibrillators (ICDs). We sought to determine the ICD insertion rate among survivors of out-of-hospital cardiac arrest and to determine factors associated with ICD implantation.
METHODS: The Ontario Prehospital Advanced Life Support (OPALS) study is a prospective, multiphase, before-after study assessing the effectiveness of prehospital interventions for people experiencing cardiac arrest, trauma or respiratory arrest in 19 Ontario communities. We linked OPALS data describing survivors of cardiac arrest with data from all defibrillator implantation centres in Ontario.
RESULTS: From January 1997 to April 2002, 454 patients in the OPALS study survived to hospital discharge after experiencing an out-of-hospital cardiac arrest. The mean age was 65 (standard deviation 14) years, 122 (26.9%) were women, 398 (87.7%) had a witnessed arrest, 372 (81.9%) had an initial rhythm of ventricular tachycardia or ventricular fibrillation (VT/VF), and 76 (16.7%) had asystole or another arrhythmia. The median cerebral performance category at discharge (range 1-5, 1 = normal) was 1. Only 58 (12.8%) of the 454 patients received an ICD. Patients with an initial rhythm of VT/VF were more likely than those with an initial rhythm of asystole or another rhythm to undergo device insertion (adjusted odds ratio [OR] 9.63, 95% confidence interval [CI] 1.31-71.50). Similarly, patients with a normal cerebral performance score were more likely than those with abnormal scores to undergo ICD insertion (adjusted OR 12.52, 95% CI 1.74-92.12).
INTERPRETATION: A minority of patients who survived cardiac arrest underwent ICD insertion. It is unclear whether this low usage rate reflects referral bias, selection bias by electrophysiologists, supply constraint or patient preference.

Entities:  

Mesh:

Year:  2004        PMID: 15505267      PMCID: PMC526330          DOI: 10.1503/cmaj.1031627

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  23 in total

1.  Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH).

Authors:  K H Kuck; R Cappato; J Siebels; R Rüppel
Journal:  Circulation       Date:  2000-08-15       Impact factor: 29.690

2.  ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines).

Authors:  Gabriel Gregoratos; Jonathan Abrams; Andrew E Epstein; Roger A Freedman; David L Hayes; Mark A Hlatky; Richard E Kerber; Gerald V Naccarelli; Mark H Schoenfeld; Michael J Silka; Stephen L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; Gabriel Gregoratos; Loren F Hiratzka; David P Faxon; Alice K Jacobs; Valentin Fuster; Sidney C Smith
Journal:  Circulation       Date:  2002-10-15       Impact factor: 29.690

3.  Long-term outcomes of out-of-hospital cardiac arrest after successful early defibrillation.

Authors:  T Jared Bunch; Roger D White; Bernard J Gersh; Ryan A Meverden; David O Hodge; Karla V Ballman; Stephen C Hammill; Win-Kuang Shen; Douglas L Packer
Journal:  N Engl J Med       Date:  2003-06-26       Impact factor: 91.245

4.  Implantable cardioverter defibrillator utilization based on discharge diagnoses from Medicare and managed care patients.

Authors:  Jeremy N Ruskin; A John Camm; Douglas P Zipes; Alfred P Hallstrom; Mary E McGrory-Usset
Journal:  J Cardiovasc Electrophysiol       Date:  2002-01

5.  Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.

Authors:  S J Connolly; A P Hallstrom; R Cappato; E B Schron; K H Kuck; D P Zipes; H L Greene; S Boczor; M Domanski; D Follmann; M Gent; R S Roberts
Journal:  Eur Heart J       Date:  2000-12       Impact factor: 29.983

6.  Improved out-of-hospital cardiac arrest survival through the inexpensive optimization of an existing defibrillation program: OPALS study phase II. Ontario Prehospital Advanced Life Support.

Authors:  I G Stiell; G A Wells; B J Field; D W Spaite; V J De Maio; R Ward; D P Munkley; M B Lyver; L G Luinstra; T Campeau; J Maloney; E Dagnone
Journal:  JAMA       Date:  1999-04-07       Impact factor: 56.272

7.  Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.

Authors:  S J Connolly; M Gent; R S Roberts; P Dorian; D Roy; R S Sheldon; L B Mitchell; M S Green; G J Klein; B O'Brien
Journal:  Circulation       Date:  2000-03-21       Impact factor: 29.690

8.  Life-threatening ventricular arrhythmias due to transient or correctable causes: high risk for death in follow-up.

Authors:  D G Wyse; P L Friedman; M A Brodsky; K J Beckman; M D Carlson; A B Curtis; A P Hallstrom; M H Raitt; B L Wilkoff; H L Greene
Journal:  J Am Coll Cardiol       Date:  2001-11-15       Impact factor: 24.094

9.  Survivors of ventricular tachyarrhythmias due to a transient or reversible disorder have a high recurrence rate of lethal cardiac events.

Authors:  Andreas Kliegel; Philip Eisenburger; Fritz Sterz; Michael Holzer; Heidrun Losert; Christof Havel; Günter Stix; Anton N Laggner
Journal:  Resuscitation       Date:  2002-09       Impact factor: 5.262

Review 10.  Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials.

Authors:  Justin A Ezekowitz; Paul W Armstrong; Finlay A McAlister
Journal:  Ann Intern Med       Date:  2003-03-18       Impact factor: 25.391

View more
  1 in total

1.  Use of implantable cardioverter defibrillators in Canadian and US survivors of out-of-hospital cardiac arrest.

Authors:  David H Birnie; Christie Sambell; Helen Johansen; Kathryn Williams; Robert Lemery; Martin S Green; Michael H Gollob; Douglas S Lee; Anthony S L Tang
Journal:  CMAJ       Date:  2007-07-03       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.